Bicester, UK, 17 October 2023: Cherwell, specialists in cleanroom microbiology solutions for the pharmaceutical, healthcare and related industries, is to participate in a number of open discussions ...

Par Health, Inc. ("Par Health" or the "Company") today announced that it has successfully completed its previously announced spin-off from ...

Curia’s global API aseptic processing manufacturing network has served a broad portfolio of customers worldwide for more than 20 years. This investment positions the company to support increasingly ...

Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, ...

“Really educational course. Good dynamic between lecture and teamwork. Not just a read through of guidelines but a proper insight to what is GMP. The course has changed my mindset on manufacturing of ...

Manufacturers must figure out how flexible they need to be to meet the numerous new requirements of the changing therapeutic and regulatory landscapes. Largely driven by this exponential increase in ...

This report, published by Towards Healthcare, a sister firm of Precedence Research, provides a comprehensive analysis of the ...

ISPE, has announced that it will soon release an update for its ISPE Baseline® Guide: Sterile-Product Manufacturing Facilities (Second Edition). This update, which is intended to replace the original ...

ALBANY, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced its Burlington, MA sterile drug ...

According to the National Cancer Institute, immunotherapies that enlist and strengthen the power of a patient’s immune system are the “fifth pillar” of cancer treatment adding to surgery, chemotherapy ...